↓ Skip to main content

Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
11 X users
reddit
1 Redditor

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
23 Mendeley